• Jurecic Lab

Dr. Jurecic studies the characterization of cancer and chemotherapy-induced acute and long-term adverse effects on the function of the hematopoietic and immune systems in cancer patients and cancer survivors. He also aims to develop and test new therapeutic approaches to improve hematologic and immune competence of cancer patients and cancer survivors by attenuating or preventing acute and chronic adverse effects of cancer and chemotherapy. His research also explores the function of HSCs and hematopoietic and immune systems under stress and injury conditions (cancer, chemotherapy, infections).